异种抗血清有抗癌作用,但效果短暂,而且常有严重的副作用。最近几年临床研究结果表明,采用单克隆抗体作为特异性免疫疗法是非常有用的,但也发现一些新问题。如果这些问题可以解决,单克隆抗体可能成为目前治疗癌症的有力的辅助工具。本文集中讨论单克隆抗体治疗人白血病和淋巴瘤。 Heterologous antiserum has anti-cancer effects, but the effect is brief, and often have serious side effects. In recent years, clinical studies have shown that the use of monoclonal antibodies as a specific immunotherapy is very useful, but also found some new problems. If these problems can be solved, monoclonal antibodies may become a powerful aide to cancer treatment. This article focuses on monoclonal antibodies for the treatment of human leukemia and lymphoma.